Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals in the extension of indication “relief of broncho-obstructive symptoms in patients with chronic obstructive pulmonary disease”.
Clinical Benefit
| Substantial |
Le service médical rendu par FORMOAIR 12 microgrammes/dose, solution pour inhalation en flacon pressurisé est important.
|
Clinical Added Value
| no clinical added value |
FORMOAIR 12 microgrammes/dose, solution pour inhalation en flacon pressurisé n'apporte pas d'amélioration du service médical rendu (ASMR V) par rapport aux autres bronchodilatateurs de longue durée d'action disponibles dans cette indication.
|
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
yukXcarVJAJcGPwx
